AstraZeneca and its global biologics research and development arm, MedImmune, have chosen Cambridge as the base for a pioneering new genomics research centre.
Over the last five years, electronic health records (EHRs) have been widely implemented in the United States, and health care systems now have access to vast amounts of data. While they are beginning to apply “big data” techniques to predict individual outcomes like post-operative complications and diabetes risk, big data remains largely a buzzword, not a reality, in the routine delivery of health care. Health systems are still learning how to broadly apply such analytics, outside of case examples, to improve patient outcomes while reducing spending.
AstraZeneca is making a bold genomics play that places it at the forefront of the precision medicine game: Company-wide, it’s going to use data insights from a huge swath of genomes to inform the future of its drug development.
The search for a new president and CEO for the Economic Alliance of Greater Baltimore ended before it began as the alliance appointed the woman it initially gave the post on an interim basis.
Shannon Landwehr, the alliance’s executive vice president, will replace Tom Sadowski, its current top executive, who has been apppointed vice chancellor for economic development for the University System of Maryland, starting May 2.
After flying under the radar for two years, Baltimore’s Centrexion Therapeutics ready to make its mark as an emerging pharmaceutical company in the field of pain management.
The Center for Biotechnology at Stony Brook University and the Feinstein Institute for Medical Research, the research arm of Northwell Health, announced that the Feinstein Institute will be joining the Long Island Bioscience Hub (LIBH).
From Johns Hopkins in Baltimore to the NIH in Bethesda, Maryland has the talent and institutions to become one of the biggest hubs of the bio- and health-technology industry. But the region needs more entrepreneurship to get there.
Thursday May 19, 2016 from 5:00 PM to 7:00 PM EDT
Join us as we gear up for the BIO International Convention held in San Francisco this June! Life Science Professionals planning to attend BIO, along with those unable to make it to San Francisco, are invited to join us as we showcase the strengths of the I-270 biohealth corridor in Maryland.
A new report by the Economic Alliance of Greater Baltimore and BioHealth Innovation Inc. says Maryland must pick up the pace on entrepreneurship to be the national leader in biohealth
Ahead of the Johns Hopkins Social Innovation Lab’s Impact and Innovation Forum on April 21, we’re profiling the entrepreneurs that are part of the current cohort.
Here’s a look at three startups focused on building health solutions in Baltimore: